Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?

Lung cancer is still the leading cause of death among all cancers. During the last 15 years, pharmacogenomics of lung cancer have established targeted therapy with tyrosine kinase inhibitors (TKIs) for epidermal growth factor receptor (EGFR) positive patients in adenocarcinoma or mixed adenosquamus...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Transl Med
Autors principals: Zarogoulidis, Paul, Gaga, Mina, Huang, Haidong, Darwiche, Kaid, Rapti, Aggeliki, Hohenforst-Schmidt, Wolfgang
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2017
Matèries:
Commentary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5243233/
https://ncbi.nlm.nih.gov/pubmed/28101783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-017-0135-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars